Demant A/S, headquartered in Smørum, Denmark, is a global leader in hearing healthcare solutions. The company’s core business centers on the development, manufacturing and distribution of hearing aids, audio processors and related diagnostic equipment. Under its portfolio of brands—including Oticon, Bernafon, Sonic and Oticon Medical—Demant provides advanced technological solutions aimed at improving hearing performance and quality of life for individuals with hearing loss.
Alongside its hearing instruments division, Demant offers a comprehensive range of audiological diagnostic tools and hearing care services. These include digital hearing screening devices, fitting software and outcome measurement systems designed to support hearing care professionals. The group also manages a network of clinics and retail outlets that deliver personalized hearing assessments and rehabilitation services, ensuring a seamless continuum of care from device fitting to follow-up support.
Tracing its heritage back to the founding of Oticon in 1904, the holding company was established in 1992 under the name William Demant Holding A/S before adopting the Demant A/S identity in 2019. Over the decades, the company has expanded its footprint to serve markets in Europe, North and Latin America, Asia Pacific, the Middle East and Africa, drawing on a global research and manufacturing infrastructure to drive innovation and meet regional needs.
Under the leadership of President & CEO Niels Jacobsen, Demant invests heavily in new technologies, including digital signal processing, connectivity solutions and artificial intelligence applications for hearing healthcare. The organization emphasizes collaboration with academic institutions, clinical partners and industry stakeholders to advance evidence-based practices and foster continuous improvement in hearing solutions.
AI Generated. May Contain Errors.
